Navigation Links
BioStorage Technologies Appoints New Member to Board of Directors
Date:12/8/2011

INDIANAPOLIS, Dec. 8, 2011 /PRNewswire/ -- BioStorage Technologies, a global provider of comprehensive sample management solutions including consulting, storage, cold chain logistics and virtual sample intelligence and tracking for the bioscience industry, announced today that Thomas J. Newman, M.D., has been appointed to the company's board of directors. Dr. Newman joins BioStorage Technologies with more than 30 years of executive and leadership experience in the contract services and pharmaceutical industries.

"We are pleased to have an industry expert of Dr. Newman's caliber as a member of our board and are certain that he will provide significant contributions to the shared vision for BioStorage Technologies' growth and market expansion next year and beyond," said Gregory Swanberg, Chief Executive Officer, BioStorage Technologies. "His vast amount of experience in contract services will only add to our boards' already extensive knowledge of the pharmaceutical industry."

Most recently, Dr. Newman served as President of PharmaNet Development Group, a global drug development services company, where he was responsible for worldwide operations. He also served in various capacities of executive leadership at Covance and Bristol-Myers Squibb. Prior to joining industry he was on the faculty of the Department of Pediatrics at the University of Minnesota Medical School.

Dr. Newman received his M.D. from Tufts University School of Medicine and his Bachelor of Arts degree in biology from Cornell University.

About BioStorage Technologies, Inc.:
BioStorage Technologies, Inc. is the premier, global provider of comprehensive sample management solutions for the bioscience industry. Offering onsite or outsourced management of sample assets, BioStorage Technologies manages the complete life cycle of samples. With a team of global sample experts, state-of-the-art temperature-controlled storage facilities, and a real-time, web-based sample intelligence and tracking system, the company supports customers in maximizing opportunities, minimizing risk and reducing the cost of sample management. BioStorage Technologies, Inc. is privately held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit www.biostorage.com or call +1 (866) 697-2675 or +49-6155-898-1011.

Press Contact:
Michael Clark
Miller Brooks, Inc.
317-873-8100
michael@millerbrooks.com


'/>"/>
SOURCE BioStorage Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium at International Contract Services Expo
2. BioStorage Technologies Expands Liquid Nitrogen Storage in Germany-based Biorepository Facility
3. BioStorage Technologies, Inc. to Hold Global Sample Management Benchmarking Symposium in Conjunction With 2011 IIR Biorepositories Conference
4. BioStorage Technologies Showcases First-Ever Mobile Biorepository - Relofleet™ at Drug Information Association Annual Meeting
5. BioStorage Technologies Expands U.S. Operations with Opening of New Biorepository Facility
6. BioStorage Technologies Appoints New Director of Business Development for European Operations
7. AMDeCs Vendor Program Expands Focus with Addition of BioStorage Technologies, Offering Preferred Pricing on Tissue Storage and Cold Chain Logistics Services
8. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium in Conjunction with Biorepositories Asia Conference
9. BioStorage Technologies Introduces New Version of Web-based Tracking and Sample Management System - ISISS®
10. BioStorage Technologies Appoints New Vice President of Global Sales
11. BioStorage Technologies Brings Together Industry Leaders for Global Sample Management Benchmarking Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the ... at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application ... team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
Breaking Biology Technology:
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... has awarded the 44 million US Dollar project, ... Security Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... world leader in the production and implementation of Identity Management ... in January, however Decatur was selected ...
Breaking Biology News(10 mins):